Swiss Marine and Shipping Stock News

Sika has successfully completed the placement of CHF 600 million in bonds across three tranches, with maturities spanning from 2027 to 2034 and yields ranging from 0.45% to 1.16%, which will be listed on the SIX Swiss Exchange. This multi-tranche bond issuance was designed to optimize Sika’s funding structure and enhance financial flexibility by lowering overall group-wide funding costs. We’ll explore how Sika’s strengthened funding profile may influence its investment narrative and future...

In the past week, Roche announced a series of major developments, including the European Commission's conditional approval of Lunsumio subcutaneous for relapsed/refractory follicular lymphoma, positive phase III results for fenebrutinib in multiple sclerosis, and a new clinical trial collaboration with KaliVir Immunotherapeutics to advance novel combination immunotherapies in oncology. These milestones highlight Roche's continued expansion across oncology and neurology, with new treatment...

Avolta (SWX:AVOL) is making moves across the Asia Pacific, entering Japan’s Kansai Airport with new retail ideas and debuting refreshed stores in Perth. The company’s latest loyalty partnership in Thailand also signals deeper customer engagement. See our latest analysis for Avolta. While Avolta’s latest moves in Japan, Australia, and Thailand have made headlines, the market story goes deeper. The stock’s year-to-date share price return sits at an impressive 18.96%, and the one-year total...

Barry Callebaut (SWX:BARN) stock came into focus after Goldman Sachs initiated coverage with a Buy rating, signaling increased attention from market participants. This move suggests broader confidence in the company’s mid-term prospects and ongoing transformation. See our latest analysis for Barry Callebaut. Momentum has started to build for Barry Callebaut, with its strategic partnership with NotCo AI and a recently affirmed dividend highlighting its transformation agenda. While the 90-day...

Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...

At the Bloomberg New Economy Forum in Singapore, ABB recently reaffirmed its mid-term revenue growth target of 5–7% annually on a comparable basis and raised its operational earnings margin goal to 18–22%. While the increased profitability target marked a positive step, the decision not to lift sales growth guidance, despite stronger targets from peers, stood out to industry observers and investors. We'll examine how ABB's decision to maintain its sales growth target, even as peers raise...

On November 18, 2025, u-blox Holding AG (SWX:UBXN) was removed from the S&P Global BMI Index, a widely tracked global benchmark for equities. This index exclusion can influence trading behavior, as passive funds often adjust their portfolios to align with index changes, potentially impacting liquidity. We'll now consider how the index removal and subsequent fund adjustments may shape u-blox Holding's broader investment narrative. We've found 15 US stocks that are forecast to pay a dividend...

As global markets navigate the aftermath of the longest U.S. government shutdown in history, investors are observing mixed performances across major indices, with small-cap stocks particularly underperforming due to heightened sensitivity to interest rate movements and ongoing concerns about elevated valuations. In this environment, identifying high-growth tech stocks requires a focus on companies that can demonstrate resilience and adaptability amid economic uncertainties and shifting market...

Key Insights Given the large stake in the stock by institutions, Landis+Gyr Group's stock price might be vulnerable to...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Galderma recently presented new clinical data from its Restylane and Sculptra portfolios at the American Society for Dermatologic Surgery 2025 Annual Meeting in Chicago, including results that supported the recent FDA approval of Restylane Lyft for chin augmentation in adults. This new data not only highlights high patient satisfaction and durable results for the company’s injectable aesthetics but also addresses emerging needs among patients experiencing facial changes following...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Food industry in Switzerland, you could be...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Interroll Holding AG's ( VTX:INRN ) price-to-earnings (or "P/E") ratio of 30.7x might make it look like a strong sell...

The last three months have been tough on ARYZTA AG ( VTX:ARYN ) shareholders, who have seen the share price decline a...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Earlier this month, Galenica AG announced the successful placement of a CHF 250 million fixed rate bond with a 7-year term and a 1.08% annual coupon, set to mature in 2032 and managed by UBS. This move enables Galenica to refinance bridge financing from its Labor Team Group acquisition, lowers short-term liabilities, and further strengthens its long-term capital structure. We will now examine how extending Galenica’s debt maturity profile through this bond may influence the company’s...

Temenos was recently named a Leader in the IDC MarketScape for North America Retail Digital Banking Solutions 2025–2026, highlighting the company’s flexible architecture, scale, reliability, and robust ecosystem integration. In addition, Temenos launched its Innovation Hub in Central Florida, aiming to advance US banking solutions with transformative technologies like Generative AI. We'll explore how Temenos’ industry leadership positioning and AI-driven US innovation focus shapes its...

PSP Swiss Property (SWX:PSPN) just released its third quarter and nine-month 2025 earnings, drawing attention with a blend of steady sales, a dip in quarterly profit, and higher net income over nine months. See our latest analysis for PSP Swiss Property. PSP Swiss Property’s latest results arrive with the stock up 7.6% year-to-date, and a notably strong total shareholder return of nearly 16% over the past twelve months. The steady sales and uptick in nine-month net income appear to be keeping...

Tecan Group (SWX:TECN) has revealed that CFO Tania Micki will be leaving the company to pursue an external opportunity, with her planned departure scheduled for May 2026. This kind of transition, especially in a key financial role, often prompts investors to consider what it could mean for future strategy and company performance. See our latest analysis for Tecan Group. Following news of CFO Tania Micki’s planned departure, Tecan’s share price has continued its recent downward momentum,...

Sika (SWX:SIKA) has completed a CHF 600 million bond issue across three tranches, attracting significant investor interest. The offering aims to bolster the company’s funding flexibility and assist in refinancing existing financial obligations. See our latest analysis for Sika. Amid the news of Sika’s successful bond placement, it is worth noting that momentum in the company’s shares has faded this year. The year-to-date share price return is -30.39%, and the 1-year total shareholder return...

In a recent update, Dätwyler Holding AG announced new medium-term financial targets, projecting an EBIT margin above 17% and annual organic revenue growth in the higher single-digit percentage range. This guidance signals management’s increased confidence in both operational improvement and profitability, underlining the company's positive outlook for future performance. We'll examine how Dätwyler's ambitious margin target and growth expectations could influence the company's investment...